TA
TMO icon

Tiedemann Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Tiedemann Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$335K Sell
661
-4
-0.6% -$2.13K 0.01% 208
2023
Q2 		$347K Buy
665
+4
+0.6% +$2.16K 0.01% 192
2023
Q1 		$381K Hold
661
– – 0.02% 185
2022
Q4 		$364K Hold
661
– – 0.02% 179
2022
Q3 		$336K Sell
661
-7
-1% -$3.92K 0.02% 176
2022
Q2 		$363K Sell
668
-37
-5% -$20.4K 0.03% 174
2022
Q1 		$416K Buy
705
+61
+9% +$35K 0.02% 203
2021
Q4 		$430K Sell
644
-1
-0.2% -$624 0.02% 204
2021
Q3 		$369K Sell
645
-1,627
-72% -$893K 0.02% 221
2021
Q2 		$1.15M Buy
2,272
+172
+8% +$81.2K 0.05% 160
2021
Q1 		$961K Sell
2,100
-93
-4% -$44.4K 0.04% 165
2020
Q4 		$1.02M Buy
2,193
+48
+2% +$22.5K 0.05% 149
2020
Q3 		$947K Sell
2,145
-284
-12% -$117K 0.05% 175
2020
Q2 		$880K Buy
2,429
+260
+12% +$87.1K 0.05% 172
2020
Q1 		$616K Buy
2,169
+31
+1% +$9.78K 0.04% 187
2019
Q4 		$697K Sell
2,138
-8,209
-79% -$2.49M 0.03% 189
2019
Q3 		$3.01M Buy
10,347
+8,345
+417% +$2.39M 0.14% 93
2019
Q2 		$588K Sell
2,002
-4,439
-69% -$1.22M 0.03% 188
2019
Q1 		$1.76M Buy
6,441
+338
+6% +$84.1K 0.08% 147
2018
Q4 		$1.37M Buy
6,103
+4,567
+297% +$1.07M 0.07% 165
2018
Q3 		$375K Buy
1,536
+18
+1% +$4.14K 0.02% 242
2018
Q2 		$315K Buy
1,518
+247
+19% +$52.4K 0.02% 253
2018
Q1 		$263K Buy
1,271
+170
+15% +$35.7K 0.02% 236
2017
Q4 		$209K Hold
1,101
– – 0.02% 210
2017
Q3 		$209K Sell
1,101
-1,895
-63% -$343K 0.02% 319
2017
Q2 		$523K Buy
+2,996
New +$503K 0.04% 315

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Tiedemann Advisors's TMO Position: Q3 2023 in Review

Tiedemann Advisors reduced its Thermo Fisher Scientific (TMO) stake by 0.6% in Q3 2023, selling an estimated $2.13K and leaving 661 shares worth $335K. The position accounts for 0.01% of the portfolio, ranked #208.

Tiedemann Advisors first reported a position in TMO in Q2 2017 and has held it in 26 quarters since. The position peaked at $3.01M in Q3 2019. 2,366 funds tracked by Wall St. Rank hold TMO as of Q3 2023.

  • Tiedemann Advisors held 661 shares of Thermo Fisher Scientific worth $335K as of Q3 2023.
  • Tiedemann Advisors sold 4 Thermo Fisher Scientific shares in Q3 2023, an estimated $2.13K.
  • Thermo Fisher Scientific made up 0.01% of Tiedemann Advisors's portfolio in Q3 2023, its #208 holding.
  • Tiedemann Advisors first reported a position in Thermo Fisher Scientific in Q2 2017 and has held it in 26 quarters since.
  • Tiedemann Advisors's Thermo Fisher Scientific position peaked at $3.01M in Q3 2019.
  • 2,366 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2023.

Based on Tiedemann Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.